Jim Cramer wonders how far GE Vernova ( GEV ) could have gone.


We recently published 11 stocks on Jim Cramer’s radar. GE Vernova Inc. (NYSE:GEV) is one of the stocks on Jim Cramer’s radar.

GE Vernova Inc. (NYSE:GEV) is a nuclear power company that supplies reactors. The company also manufactures and sells gas turbines, wind turbines and other heavy equipment. The firm has seen a flurry of coverage from analysts lately. For example, BMO raised its price target on shares of GE Vernova Inc. (NYSE:GEV) to $785 from $780 and maintained an outperform rating on the stock. In its coverage, the financier commented on the company’s estimates of leaving 2026 with 100 GW in gas turbine commitments. BMO also discussed the acquisition by GE Vernova Inc. (NYSE:GEV) of transformer maker Prolec, as he noted that the deal could create significant synergies. UBS also raised its price target on the stock. He raised the target to $936 from $835 and maintained a buy rating on the stock. The bank commented that the fourth quarter earnings of GE Vernova Inc. (NYSE:GEV) had indicated margin strength for the company’s medium-term operations. As stocks soared after earnings, Cramer tweeted:

“Nobody seems to know how far to take GE Vernova. They should already own… club name”

While we recognize the potential of GEV as an investment, our conviction lies in the belief that some AI stocks are more promising to deliver higher returns and have limited downside risk. If you’re looking for an extremely cheap AI stock that’s also a big beneficiary of Trump’s tariffs and onshoring, check out our free report on the best short term AI stock.

READ THE FOLLOWING: 30 stocks that should double in 3 years i 11 Hidden AI Stocks to Buy Right Now.

Disclosure: no. This article is originally published in Monkey Insider.



Source link

  • Related Posts

    Piper Sandler raises Bristol Myers (BMY) PT to $66 citing pipeline visibility

    Bristol Myers Squibb Company (NYSE:BMY) is one of the the most undervalued large-cap stocks to invest in now. On January 28, Piper Sandler raised its price target for Bristol Myers…

    Elon Musk’s SpaceX buys xAI in rare deal worth $1.25 trillion ahead of IPO

    Elon Musk’s rocket company SpaceX THERE Obtained xAI, the artificial intelligence firm founded by Musk three years ago, in a large, and unconventional, deal that combines two private companies into…

    Leave a Reply

    Your email address will not be published. Required fields are marked *